Delivery Order SPE2D019D0002-SPE2D325F335B
- Not listed
- The Defense Logistics Agency Troop Support Medical awarded a $74 firm fixed price delivery order contract to The Harvard Drug Group, L.L.C. for 500 count bottles of 600mg ibuprofen tablets. Performance will occur in Livonia, Michigan by September 2023. The Harvard Drug Group, L.L.C. operates its Major Pharmaceuticals division and is a subsidiary of Cardinal Health, Inc. This delivery order was issued under an existing pharmaceuticals contract vehicle held by the agency to supply pain...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,690.60 delivery order contract is for the supply of 4565265395 Ibuprofen 800 mg tablets in 500-count bottles. The contract is a firm fixed-price arrangement with a completion date of July 29, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,563.33. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of Ibuprofen 800 mg tablets. The contract has an ultimate completion date of June 17, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,550.19 firm fixed-price delivery order is for the supply of 4,560,784,621 units of Ibuprofen 800 mg tablets. The contract has an ultimate completion date of May 2, 2023. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies, particularly the Department...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Humira (cf) Pen 40 mg/0.4 mls, a pharmaceutical product used primarily for the treatment of inflammatory conditions. This firm fixed price delivery order, valued at $1,510.60, represents a non-set-aside competitive award with an ultimate completion date of August 13, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- This federal contract award, valued at $1,148.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,768,287 units of 400 mg ibuprofen tablets in 500-count packages. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is a $999,999,999 IDC running through November 2026 that provides a...
- The Defense Department's Medical Supply Chain awarded a $4,767.26 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the procurement of Ibuprofen 800 mg tablets (500-count units). This is a firm fixed price, competitively awarded contract with performance to be completed by July 21, 2025, and will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. No set-aside provisions were applied to this award. This delivery order is issued under...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $7,719.24 for the supply of Humira (CF) Pen 40 mg/0.4 mls. The award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, for the supply of Haloperidol 1 mg tablets in quantities of 1,000 units. The contract is structured as a firm fixed price delivery order with a ceiling value of $2,328.58 and an ultimate completion date of August 8, 2025. The award was competitively awarded with no set-aside...
- This federal contract award is for the delivery of Humira (adalimumab) pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $9,280.92 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs,...
- SPE2D019D0002Indefinite Delivery Contract
- SPE2D019D0002-SPE2D325F335BDelivery Order
The Harvard Drug Group, L.L.C., a Native Hawaiian Organization-owned pharmaceutical distributor and subsidiary of Cardinal Health, Inc., was awarded a delivery order on August 20, 2025, by the Medical Supply Chain (an alternate name for Defense Logistics Agency Troop Support Medical) for the supply of Ibuprofen 800 mg tablets in quantities of 500 units. This firm fixed-price delivery order carries a ceiling value of $1,787.80 and an ultimate completion date of August 25, 2025. The performance location is identified as La Vergne, Tennessee, where The Harvard Drug Group maintains its headquarters. No small business set-aside designation was applied to this award, indicating competition was conducted on an unrestricted basis. This delivery order represents a routine pharmaceutical procurement under The Harvard Drug Group's broader Federal Supply Schedule contract with the Department of Veterans Affairs National Acquisition Center, which maintains a $420.1 million ceiling through May 31, 2030, and covers drugs, pharmaceuticals, and hematology-related products. The company's established role as a critical pharmaceutical vendor for federal healthcare systems, including the Department of Defense and Veterans Affairs, positions it to fulfill this essential medical supply requirement efficiently across the federal healthcare infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/20/25 |